| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |